Does Rallies show 13F holders for PASG?

Yes. Rallies tracks hedge fund and 13F ownership data for PASG, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PASG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PASG. It does not provide personalized investment advice.

PASG (Passage Bio, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Passage Bio, Inc. Common Stock (PASG) is a publicly traded Healthcare sector company. As of May 21, 2026, PASG trades at $5.00 with a market cap of $16.42M and a P/E ratio of -0.37. PASG moved +5.31% today. Year to date, PASG is -67.72%; over the trailing twelve months it is -17.25%. Its 52-week range spans $3.94 to $26.60. Analyst consensus is neutral with an average price target of $11.75. Rallies surfaces PASG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PASG stock?

Hedge funds tracked by Rallies that own PASG include Orbimed Advisors. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Passage Bio, Inc. Common Stock.

PASG Key Metrics

Key financial metrics for PASG
Metric	Value
Price	$5.00
Market Cap	$16.42M
P/E Ratio	-0.37
EPS	$-14.35
Dividend Yield	0.00%
52-Week High	$26.60
52-Week Low	$3.94
Volume	162
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-45.52M
Gross Margin	0.00%

Top Hedge Funds Holding PASG

Orbimed Advisors holds 59.05K shares of PASG, changed -99.02% as of Sep 30, 2025.

Latest PASG News

Passage Bio’s Trial Shows 64% Brain Atrophy Reduction, FDA Demands RCT — Apr 20, 2026

Recent PASG Insider Trades

Chou William sold 4.08K (~$75.16K) on Jan 8, 2026.
Borthwick Kathleen sold 2.06K (~$38.02K) on Jan 8, 2026.
Lynx1 Capital Management LP bought 11.90K (~$83.18K) on Sep 15, 2025.

PASG Analyst Consensus

5 analysts cover PASG: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $11.75.

Common questions about PASG

Who owns PASG stock?: Hedge funds tracked by Rallies that own PASG include Orbimed Advisors. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Passage Bio, Inc. Common Stock.
Does Rallies show 13F holders for PASG?: Yes. Rallies tracks hedge fund and 13F ownership data for PASG, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PASG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PASG. It does not provide personalized investment advice.